Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens

Acta Radiologica Open
Jan H GeismarLars Husmann

Abstract

18F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/ computed tomography (CT) imaging demands guidelines to safeguard sufficient image quality at low radiation exposure. Various FDG dose regimes have been investigated; however, body weight-adapted dose regimens and related image quality (IQ) have not yet been compared in the same patient. To investigate the relationship between FDG dosage and image quality in PET/CT in the same patient and determine prerequisites for low dosage scanning. This study included 61 patients undergoing a clinically indicated PET/CT imaging study and follow-up with a normal (NDS, 5 MBq/kg body weight [BW]) and low dosage scanning protocol (LDS, 4 MBq/kg BW), respectively, using a Discovery VCT64 scanner. Two blinded and independent readers randomly assessed IQ of PET using a 5-point Likert scale and signal-to-noise ratio (SNR) of the liver. Body mass index (BMI) was significantly lower at LDS (P = 0.021) and represented a significant predictor of SNR at both NDS (P < 0.001) and LDS (P = 0.005). NDS with a mean administered activity of 340 MBq resulted in significantly higher IQ (P < 0.001) and SNR as compared with LDS with a mean of 264 MBq (F-value = 23.5, P < 0.001, mixed model A...Continue Reading

References

Dec 17, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Mitsuaki TatsumiRichard L Wahl
Sep 25, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Hendrik EveraertPhilippe R Franken
Sep 8, 2006·Nihon Hoshasen Gijutsu Gakkai zasshi·Keiichi MatsumotoMichio Senda
May 17, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Marine SoretIrène Buvat
Jul 31, 2007·European Journal of Nuclear Medicine and Molecular Imaging·M TeräsJ Knuuti
Apr 22, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ronald Boellaard
May 16, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yoko MasudaKiyoko Kusakabe
Nov 17, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Ronald BoellaardBernd J Krause
Jan 29, 2010·Physics in Medicine and Biology·Martin A LodgeRichard L Wahl
Feb 18, 2010·IEEE Transactions on Nuclear Science·Kisung LeePaul E Kinahan
May 26, 2010·Current Pharmaceutical Biotechnology·By Hao Peng, Craig S Levin
May 27, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Babak SabouryAbass Alavi
Jan 15, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Catherine M LockhartPaul E Kinahan
Jul 28, 2011·Physics in Medicine and Biology·Tingting ChangOsama R Mawlawi
Sep 7, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Go AkamatsuMasayuki Sasaki
May 29, 2013·Acta Oncologica·Mona-Elisabeth RevheimTherese Seierstad
Aug 9, 2013·Annals of Nuclear Medicine·Garry M McDermottAndrew F Scarsbrook
Aug 14, 2013·EJNMMI Research·Eleonore H de GrootJorn A van Dalen
Dec 5, 2013·Clinical Nuclear Medicine·Ai-ping ChengWei-ying Sun
Dec 26, 2013·Clinical Nuclear Medicine·Gang ChengScott R Akers

❮ Previous
Next ❯

Software Mentioned

SPSS Statistics
package mgcv R
Advantage Windows

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica
Michael J Gelfand
© 2021 Meta ULC. All rights reserved